MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
Apollo Endosurgery DIO Ratio 2011-2026 | APEN
Annual DIO Ratio Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160 | 145 | 190 | 129 | 131 | 213 | 176 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 213 | 129 | 163 |
Quarterly DIO Ratio Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 86.2 | - | 158 | - | 142 | 130 | 150 | - | 161 | 293 | 172 | - | 139 | 114 | 144 | - | 142 | 137 | 169 | - | 218 | 197 | 237 | - | 211 | 121 | 232 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 293 | 86.2 | 168 |
DIO Ratio of other stocks in the Medical devices industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
108 | - | -26.83 % | $ 2.62 M |  USA |
 |
Alphatec Holdings
ATEC
|
271 | $ 13.94 | -0.71 % | $ 2.09 B | USA |
 |
Allied Healthcare Products
AHPI
|
133 | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
220 | $ 14.09 | -7.06 % | $ 381 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
75.1 | - | - | $ 1.77 B | USA |
 |
Lianluo Smart Limited
LLIT
|
50 | - | 24.59 % | $ 44.8 M |  China |
 |
Avinger
AVGR
|
332 | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
240 | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
238 | $ 31.87 | 2.07 % | $ 1.47 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
76.7 | $ 7.0 | 5.74 % | $ 503 M |  Israel |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 4.38 | -4.58 % | $ 163 M |  France |
 |
Axonics Modulation Technologies
AXNX
|
290 | - | - | $ 3.31 B | USA |
 |
Electromed
ELMD
|
91.2 | $ 24.18 | 1.09 % | $ 204 M | USA |
 |
Aziyo Biologics
AZYO
|
108 | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
213 | $ 3.49 | 2.05 % | $ 121 M | USA |
 |
Conformis
CFMS
|
160 | - | - | $ 16.4 M | USA |
 |
Bio-Rad Laboratories
BIO
|
237 | $ 275.33 | 2.19 % | $ 7.77 B | USA |
 |
BIOLASE
BIOL
|
154 | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
216 | $ 40.88 | 2.48 % | $ 6.09 K | USA |
 |
BioSig Technologies
BSGM
|
7.1 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
169 | $ 75.65 | 2.97 % | $ 112 B | USA |
 |
InMode Ltd.
INMD
|
307 | $ 14.0 | 0.29 % | $ 905 M | Israel |
 |
IRIDEX Corporation
IRIX
|
125 | $ 1.47 | -2.0 % | $ 23.7 M | USA |
 |
IRadimed Corporation
IRMD
|
251 | $ 102.4 | 1.89 % | $ 1.3 B | USA |
 |
CryoLife, Inc.
CRY
|
312 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
247 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
205 | $ 45.89 | -0.18 % | $ 1.42 B | USA |
 |
Cardiovascular Systems
CSII
|
192 | - | 0.15 % | $ 844 M | USA |
 |
LivaNova PLC
LIVN
|
127 | $ 71.26 | 1.38 % | $ 3.89 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
212 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
272 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
10.1 | - | - | $ 111 M |  Canada |
 |
Cutera
CUTR
|
135 | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
168 | $ 97.22 | 0.58 % | $ 125 B | USA |
 |
Delcath Systems
DCTH
|
302 | $ 9.11 | -10.77 % | $ 260 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
32.1 | $ 2.48 | 1.02 % | $ 146 M | Israel |
 |
Intersect ENT, Inc.
XENT
|
145 | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
91.1 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
85.3 | - | - | $ 10.2 M | USA |
 |
Second Sight Medical Products
EYES
|
175 | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
511 | $ 77.41 | -1.12 % | $ 2.18 B |  Costa-rica |
 |
Insulet Corporation
PODD
|
210 | $ 251.74 | 1.46 % | $ 17.7 B | USA |
 |
Quanterix Corporation
QTRX
|
138 | $ 6.7 | 6.52 % | $ 252 M | USA |
 |
GBS
GBS
|
143 | - | -0.57 % | $ 7.12 M | USA |
 |
FONAR Corporation
FONR
|
13.9 | $ 18.53 | -0.3 % | $ 121 M | USA |
 |
Sintx Technologies
SINT
|
456 | $ 2.89 | -1.87 % | $ 10.8 M | USA |
 |
MiMedx Group
MDXG
|
123 | $ 4.97 | -5.78 % | $ 735 M | USA |